Tag: Cezary Kozanecki

Synektik posts record Q3 results as revenue jumps 89%

Synektik Group increased its revenue by 89% year on year to PLN 292.3 million in the third quarter of the 2025 financial year. EBITDA...

Edison Histotripsy System Receives CE Certification for Liver Tumour Treatment

The Edison system, developed by US-based HistoSonics and using histotripsy technology for the non-invasive treatment of liver tumours, has received CE certification authorising its...

Synektik Posts Record Results as Revenue Rises to PLN 441.2 Million and EBITDA Reaches PLN 118 Million

Synektik, a listed provider of advanced medical technologies and producer of radiopharmaceuticals, closed the first half of its 2025 financial year with the highest...

Synektik Enters the Ukrainian Market and Plans to Install Around 20 da Vinci Robotic Systems

Synektik is beginning operational activity on the Ukrainian market. A local company and team have already been established in Ukraine to handle sales and...

Syn2bio Set for Warsaw Stock Exchange Debut as Synektik Split Is Finalized

On March 27, 2026, the registry court entered into the National Court Register (KRS) the increase in Syn2bio’s share capital related to the issuance...

Synektik Shareholders Approve Spin-Off; Syn2bio Set for Warsaw Stock Exchange Debut

The Extraordinary General Meeting of Synektik has unanimously approved the division of the listed company, under which its business related to research on a...

Syn2bio Files Prospectus with the Polish Financial Supervision Authority as Synektik Advances Towards Corporate Split

Syn2bio – the newly established company to which Synektik plans to transfer its activities related to research on its cardiotracer and the future commercialization...
HomeTagsCezary Kozanecki